Identification of mRNA isoform switching in breast cancer

[1]  D. Bates,et al.  Hallmarks of alternative splicing in cancer , 2014, Oncogene.

[2]  Benjamin J. Raphael,et al.  Multiplatform Analysis of 12 Cancer Types Reveals Molecular Classification within and across Tissues of Origin , 2014, Cell.

[3]  C. Perou,et al.  Comparison of RNA-Seq by poly (A) capture, ribosomal RNA depletion, and DNA microarray for expression profiling , 2014, BMC Genomics.

[4]  Yael Mandel-Gutfreund,et al.  RBPmap: a web server for mapping binding sites of RNA-binding proteins , 2014, Nucleic Acids Res..

[5]  David Haussler,et al.  The UCSC Genome Browser database: 2014 update , 2013, Nucleic Acids Res..

[6]  W. Curran,et al.  Novel small-molecule inhibitors of Bcl-XL to treat lung cancer. , 2013, Cancer research.

[7]  S. Fuqua,et al.  RNA sequencing of cancer reveals novel splicing alterations , 2013, Scientific Reports.

[8]  A. Kozubík,et al.  The planar cell polarity pathway drives pathogenesis of chronic lymphocytic leukemia by the regulation of B-lymphocyte migration. , 2013, Cancer research.

[9]  A. Quintás-Cardama,et al.  Molecular Pathways: JAK/STAT Pathway: Mutations, Inhibitors, and Resistance , 2013, Clinical Cancer Research.

[10]  Helga Thorvaldsdóttir,et al.  Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration , 2012, Briefings Bioinform..

[11]  Steven J. M. Jones,et al.  Comprehensive molecular portraits of human breast tumours , 2013 .

[12]  F. Rousset,et al.  RBFOX2 Is an Important Regulator of Mesenchymal Tissue-Specific Splicing in both Normal and Cancer Tissues , 2012, Molecular and Cellular Biology.

[13]  Steven J. M. Jones,et al.  Comprehensive molecular portraits of human breast tumors , 2012, Nature.

[14]  Ulrich Lehmann,et al.  Nuclear Kaiso Expression Is Associated with High Grade and Triple-Negative Invasive Breast Cancer , 2012, PloS one.

[15]  Naoko Okumura,et al.  Alternative splicings on p53, BRCA1 and PTEN genes involved in breast cancer. , 2011, Biochemical and biophysical research communications.

[16]  Colin N. Dewey,et al.  RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome , 2011, BMC Bioinformatics.

[17]  Nicholas C. Flytzanis,et al.  An EMT–Driven Alternative Splicing Program Occurs in Human Breast Cancer and Modulates Cellular Phenotype , 2011, PLoS genetics.

[18]  N. Friedman,et al.  Trinity: reconstructing a full-length transcriptome without a genome from RNA-Seq data , 2011, Nature Biotechnology.

[19]  Karine Tremblay,et al.  Alternative splicing of SYK regulates mitosis and cell survival , 2011, Nature Structural &Molecular Biology.

[20]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[21]  J. Manley,et al.  Alternative pre-mRNA splicing regulation in cancer: pathways and programs unhinged. , 2010, Genes & development.

[22]  C. Cooper,et al.  Elevated NCOR1 disrupts PPARalpha/gamma signaling in prostate cancer and forms a targetable epigenetic lesion. , 2010, Carcinogenesis.

[23]  Derek Y. Chiang,et al.  MapSplice: Accurate mapping of RNA-seq reads for splice junction discovery , 2010, Nucleic acids research.

[24]  Lior Pachter,et al.  Exon-Level Microarray Analyses Identify Alternative Splicing Programs in Breast Cancer , 2010, Molecular Cancer Research.

[25]  Sherif Abou Elela,et al.  Cancer-associated regulation of alternative splicing , 2009, Nature Structural &Molecular Biology.

[26]  A. Nobel,et al.  Supervised risk predictor of breast cancer based on intrinsic subtypes. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[27]  Sherif Abou Elela,et al.  Identification of alternative splicing markers for breast cancer. , 2008, Cancer research.

[28]  Eric T. Wang,et al.  Alternative Isoform Regulation in Human Tissue Transcriptomes , 2008, Nature.

[29]  L. Corcos,et al.  E2F1 controls alternative splicing pattern of genes involved in apoptosis through upregulation of the splicing factor SC35 , 2008, Cell Death and Differentiation.

[30]  Marcel H. Schulz,et al.  A Global View of Gene Activity and Alternative Splicing by Deep Sequencing of the Human Transcriptome , 2008, Science.

[31]  Brad T. Sherman,et al.  Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.

[32]  I. Ng,et al.  Prickle-1 negatively regulates Wnt/beta-catenin pathway by promoting Dishevelled ubiquitination/degradation in liver cancer. , 2006, Gastroenterology.

[33]  G. Matlashewski,et al.  Regulation of Human p53 Activity and Cell Localization by Alternative Splicing , 2004, Molecular and Cellular Biology.

[34]  Albert B. Reynolds,et al.  A core function for p120-catenin in cadherin turnover , 2003, The Journal of cell biology.

[35]  C. Fiorentini,et al.  Erratum: p120 catenin is required for growth factor-dependent cell motility and scattering in epithelial cells (Molecular Biology of the Cell (2003) 14 (1964-1977)) , 2003 .

[36]  C. Fiorentini,et al.  p120 Catenin is required for growth factor-dependent cell motility and scattering in epithelial cells. , 2003, Molecular biology of the cell.

[37]  Terrence S. Furey,et al.  The UCSC Genome Browser Database , 2003, Nucleic Acids Res..

[38]  S. Brenner,et al.  Evidence for the widespread coupling of alternative splicing and nonsense-mediated mRNA decay in humans , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[39]  Albert B. Reynolds,et al.  The p120ctn-binding partner Kaiso is a bi-modal DNA-binding protein that recognizes both a sequence-specific consensus and methylated CpG dinucleotides , 2002, Nucleic Acids Res..

[40]  W. J. Kent,et al.  BLAT--the BLAST-like alignment tool. , 2002, Genome research.

[41]  A. Bird,et al.  The p120 catenin partner Kaiso is a DNA methylation-dependent transcriptional repressor. , 2001, Genes & development.

[42]  R. Tibshirani,et al.  Significance analysis of microarrays applied to the ionizing radiation response , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[43]  S Rosenberg,et al.  Alternative and aberrant messenger RNA splicing of the mdm2 oncogene in invasive breast cancer. , 2001, Cancer research.

[44]  Yi Zheng,et al.  Inhibition of RhoA by p120 catenin , 2000, Nature Cell Biology.

[45]  À. Sierra,et al.  Bcl-xL promotes metastasis of breast cancer cells by induction of cytokines resistance , 2000, Cell Death and Differentiation.

[46]  Albert B. Reynolds,et al.  The Catenin p120ctnInteracts with Kaiso, a Novel BTB/POZ Domain Zinc Finger Transcription Factor , 1999, Molecular and Cellular Biology.

[47]  F. Neff,et al.  Expression of alternatively spliced mdm2 transcripts correlates with stabilized wild‐type p53 protein in human glioblastoma cells , 1999, International journal of cancer.

[48]  F. van Roy,et al.  Molecular cloning of the human p120ctn catenin gene (CTNND1): expression of multiple alternatively spliced isoforms. , 1998, Genomics.

[49]  H. Abe,et al.  Short alternative splice transcripts of the mdm2 oncogene correlate to malignancy in human astrocytic neoplasms. , 1998, Cancer research.

[50]  D. Neal,et al.  Alternatively spliced mdm2 transcripts with loss of p53 binding domain sequences: Transforming ability and frequent detection in human cancer , 1996, Nature Medicine.

[51]  A. Levine,et al.  The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation , 1992, Cell.